Company has every right to re-evaluate technology to provide the best outcome for shareholders through improved products. Given the various tech platforms on hand through blended companies not sure why the ex-directors thought it was their God given right to have performance bonuses served on a platter. With the limited time constraints and prioritising other tech their claims certainly dont seem to align with biotech reality.
Company has every right to re-evaluate technology to provide the...
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
48.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $53.53M | |||
| Open | High | Low | Value | Volume |
| 48.0¢ | 48.0¢ | 48.0¢ | $5.475K | 11.40K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2073 | 48.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 50.0¢ | 20153 | 2 |
View Market Depth
| Last trade - 11.22am 02/10/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |